Cargando…

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR

SIMPLE SUMMARY: Lung adenocarcinoma (LUAD) is the most common histologic subtype of lung cancer. Studies have shown that P3H4 is a key gene underlying the malignant progression of LUAD. A potential biomarker and therapeutic target, P3H4 is involved in various cancers, but its molecular mechanism in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Chen, Liang, Yingkuan, Huang, Yong, Jiang, Dong, Li, Jiaxi, Ma, Haitao, Guo, Lingchuan, Jiang, Wei, Feng, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264976/ https://www.ncbi.nlm.nih.gov/pubmed/35805016 http://dx.doi.org/10.3390/cancers14133243

Ejemplares similares

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

N (6)‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma
por: Dong, Gaochao, et al.
Publicado: (2023)

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC
por: Liang, Yingkuan, et al.
Publicado: (2022)

Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma
por: Sun, Ruizhu, et al.
Publicado: (2022)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

Long non‐coding RNA metastasis‐associated lung adenocarcinoma transcript 1 promotes lung adenocarcinoma by directly interacting with specificity protein 1
por: Li, Shufeng, et al.
Publicado: (2018)

TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect
por: Xing, Yutong, et al.
Publicado: (2020)

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations
por: Liu, Ning, et al.
Publicado: (2020)

Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression
por: Wang, Mong-Lien, et al.
Publicado: (2020)

CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification
por: Liang, Yingkuan, et al.
Publicado: (2021)

Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
por: Zhang, Te, et al.
Publicado: (2022)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations
por: Gao, Yuan, et al.
Publicado: (2017)

The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2019)

MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma
por: Li, Zhiyong, et al.
Publicado: (2020)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012)

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
por: Yang, Jiyoul, et al.
Publicado: (2018)

TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
por: Yu, Jiao-jiao, et al.
Publicado: (2020)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

SEC61G participates in endoplasmic reticulum stress by interacting with CREB3 to promote the malignant progression of lung adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2022)

Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas – Implications for the progression of EGFR-mutated lung adenocarcinomas
por: Matsumura, Mai, et al.
Publicado: (2019)

Apatinib Mesylate in the treatment of advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance —A Multicenter Randomized Trial
por: Fang, Ping, et al.
Publicado: (2019)

TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness
por: Du, Renle, et al.
Publicado: (2019)

LncRNA H19 Promotes Lung Adenocarcinoma Progression via Binding to Mutant p53 R175H
por: Zhou, Yaodong, et al.
Publicado: (2022)

Downregulation of OSR1 Promotes Colon Adenocarcinoma Progression via FAK-Mediated Akt and MAPK Signaling
por: Zhang, Fang, et al.
Publicado: (2020)

RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma
por: Bai, Xue-Song, et al.
Publicado: (2020)

GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
por: Wang, Jian, et al.
Publicado: (2020)

IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway
por: Li, Ruzhen, et al.
Publicado: (2022)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)

Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas
por: Gong, Yixuan, et al.
Publicado: (2007)

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
por: Yu, Jiang-Yong, et al.
Publicado: (2016)

USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathway
por: Zhou, Yuhui, et al.
Publicado: (2022)

Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non‐T790M mutations after progression on first‐line EGFR‐tyrosine kinase inhibitors
por: Jiang, Zhansheng, et al.
Publicado: (2018)

Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression
por: Yao, Jiaxi, et al.
Publicado: (2022)

Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma
por: Subat, Sophia, et al.
Publicado: (2018)

Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway
por: Xu, Hui, et al.
Publicado: (2021)

Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma
por: Li, Guoyin, et al.
Publicado: (2022)

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
por: Wu, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0boa0iv64dc54u9ka0ctokoj60